Bacil Pharma Ltd

NSE: BACPHAR · BSE: 524516 · Pharmaceuticals & Biotechnology · 30 announcements

Share price: ₹16.95
Market cap: ₹24.33 Cr
Revenue (annual): ₹0.00 Cr
Net profit (annual): ₹1.56 Cr
P/E (TTM): 38.5×Sector 43.8×
FII holding: 0.00%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Partnership 1 Other Announcement 1 Financial Results 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

3 announcements with these filters

4 Nov 2026 18:34 IST BSE

Partnership

Bacil Pharma Partnership

Bacil Pharma's wholly owned subsidiary signed an R&D agreement with Efdee Pharma for pharmaceutical products. The estimated project cost is Rs. 35 Crore.

Value: ₹35.00 Cr

Open announcement → Read the filing ↗

16 Oct 2026 17:22 IST BSE

Other Announcement

Bacil Pharma Other Announcement

Bacil Pharma Ltd submitted its quarterly shareholding pattern for the period ending September 30, 2026, in compliance with SEBI Regulation 31.

Open announcement → Read the filing ↗

14 Oct 2026 16:12 IST BSE

Financial Results

Bacil Pharma Q2 FY27 Results: Net Loss of ₹0.1 Cr

Bacil Pharma Ltd reported a net loss of ₹0.1 Cr for Q2 FY27.

Key figure: Net loss ₹0.1 Cr

Open full results → Read the filing ↗